3 Dividend Growth Stocks to Buy and Hold
Key PointsAbbott Laboratories is a dividend growth machine thats known for consistency.AbbVies dividend has more than quadrupled since 2013.Eli Lilly…
192,211$
-1,43%
Echtzeit-Aktienkurs ABBVIE
Bid:
Ask:
Nachrichten zur ABBVIE Aktie
AbbVie: Neuer Deal – indische Pharma-Aktie fliegt
Der US-amerikanische Pharma-Riese AbbVie baut sein Entwicklungsportfolio im Bereich der Onkologie weiter aus. Die Gesellschaft sichert sich die Rechte an…
AbbVie: Neuer Deal – indische Pharma-Aktie fliegt
Der US-amerikanische Pharma-Riese AbbVie baut sein Entwicklungsportfolio im Bereich der Onkologie weiter aus. Die Gesellschaft sichert sich die Rechte an…
ABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?
AbbVie edges ahead of Bristol Myers with strong Skyrizi and Rinvoq growth, offsetting Humira declines and portfolio headwinds.…
AbbVie (ABBV) Laps the Stock Market: Heres Why
AbbVie (ABBV) closed the most recent trading day at $195, moving +2.3% from the previous trading session.…
AbbVie stock jumps after $700 million licensing deal with IGI Therapeutics By Investing.com
AbbVie stock jumps after $700 million licensing deal with IGI Therapeutics…
LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million
Key PointsLVM Capital Management shed 16,096 shares valued at $2.58 million.LVM now holds 40,603 ICON shares valued at $5.91 million.ICON…
3 No-Brainer Stocks to Buy in July
Key PointsAbbVie offers something for every investor.Eli Lilly could be overdue for a big rally.Vertex Pharmaceuticals is in a new…
2 Dividend Stocks to Buy for Decades of Passive Income
Key PointsHealthcare giants AbbVie and Abbott Laboratories are both Dividend Kings.They should maintain their dividend growth habits for a long…
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Key PointsAbbVie is a Dividend King with solid growth prospects.Enbridge is a leading pipeline operator and natural gas utility with…
AbbVie: Q2 Earnings Warning Reflects Poor R&D, But Its Not A Red Flag
…
Is It Worth Investing in AbbVie (ABBV) Based on Wall Streets Bullish Views?
According to the average brokerage recommendation (ABR), one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after…
Can Buying the Vanguard S&P 500 ETF Make You a Millionaire?
Buying an exchange-traded fund (ETF) that tracks an index like the S&P 500 can be a great way to build…
The Zacks Analyst Blog Highlights Alphabet, AbbVie and The Walt Disney
GOOGL, ABBV, and DIS face rising costs and competition, but strong cloud, immunology, and parks growth continue to fuel optimism.…
HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best?
Artificial intelligence (AI), big tech, and cryptocurrencies all have their fans among investors, and with good reason. All can add…
Abbvie confirms $2.1bn Capstan swoop
Abbvie Inc (NYSE:ABBV) has agreed to acquire Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its pipeline…
Abbvie confirms $2.1B Capstan swoop
Abbvie Inc (NYSE:ABBV) has agreed to acquire Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its pipeline…
DGRO Is a Popular Dividend ETF for Passive Income, but Is It the Best?
Many, if not most, of us would do well to include a bunch of dividend payers in our portfolio. Naturally,…
3 Dividend Stocks to Double Up on Right Now
Buy, sell, or hold? Thats the question investors must continually ask about each stock in their portfolio.
The correct answer might…
Got $500? 2 Healthcare Stocks to Buy and Hold Forever
I dont know if well be riding in personal aircraft 20 years from now, like George Jetson did in the…
AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
AbbVie (ABBV) closed at $182.31 in the latest trading session, marking a -2.4% move from the prior day.…
5 Vanguard ETFs to Buy With $1,000 and Hold Forever
Investing in exchange-traded funds (ETFs) is a great way for both new and experienced investors to gain market exposure, and…
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock…
Heres Why AbbVie (ABBV) Fell More Than Broader Market
In the most recent trading session, AbbVie (ABBV) closed at $185.48, indicating a -2.82% shift from the previous trading day.…
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trumps plan
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…
Pfizer, AbbVie und Co unter Druck: Trump mit dem nächsten Hammer?
US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…
Pfizer, AbbVie und Co unter Druck: Trump mit dem nächsten Hammer?
US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…
AbbVies Venclexta Misses Goal in Myelodysplastic Syndromes Study
Venclexta fails to meet survival goals in ABBVs phase III MDS study, marking another clinical setback for the cancer drug.…
AbbVies Diversification Strategy Cushions Venetoclax MDS Blow
…
AbbVie fails in late-stage trial for Roche-partnered blood cancer therapy venetoclax
…
5 Large Drug Stocks That Are Poised to Ride on Sector Recovery
In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.…
2 High-Yielding ETFs That Can Generate Dividend Income for Your Portfolio for Decades
Investing in dividend stocks is a great way to generate a steady stream of recurring income for your portfolio. But…
AbbVie (ABBV) Gains As Market Dips: What You Should Know
The latest trading day saw AbbVie (ABBV) settling at $191.50, representing a +1.06% change from its previous close.…
AbbVie Inc. (ABBV) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript
…
AbbVie at Goldman Sachs Conference: Strategic Growth and Innovation By Investing.com
AbbVie at Goldman Sachs Conference: Strategic Growth and Innovation…
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
How would you like to get paid every quarter (and sometimes every month) to own a stock? Thats exactly what…
AbbVie (ABBV) Increases Despite Market Slip: Heres What You Need to Know
The latest trading day saw AbbVie (ABBV) settling at $187.66, representing a +0.17% change from its previous close.…
AbbVie (ABBV) Gains As Market Dips: What You Should Know
The latest trading day saw AbbVie (ABBV) settling at $186.11, representing a +0.26% change from its previous close.…
Better Dividend Growth ETF: Vanguard Dividend Appreciation ETF or iShares Core Dividend Growth ETF
Dividend growth stocks can be powerful investments. Hartford Funds and Ned Davis Research dug into the data on stocks based…
Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical
Berkshire Hathaway, AbbVie and Intuitive Surgical beat estimates as analysts highlight growth drivers, headwinds and strategic moves in new reports.…
CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE
NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
Elon Musk Commits to Tesla. Is That a Good Thing?
In this podcast, Motley Fool analyst Jason Moser and host Ricky Mulvey discuss:
Investing in companies with a "singular" leader, like…
2 Incredible Dividend Growth Stocks to Buy Now
Dividend growth stocks have long been reliable engines of wealth creation. Historically, companies with 10-year annualized dividend growth rates above…
The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie
Bayer, Novo Nordisk, GSK, Merck and AbbVie are part of the Zacks top Analyst Blog.…
3 Magnificent Stocks That Are Passive Income Machines
Make money without even trying: Thats what passive income is all about. But good investment alternatives are required to make…
US FDA approves AbbVies drug for a type of lung cancer
The U.S. Food and Drug Administration has approved AbbVies drug to treat adults with a type of lung cancer who…
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…
1 No-Brainer Dividend Index Fund to Buy Right Now for Less Than $500 -- and Another Dividend Fund Yielding 11%
Two of the best things in the investment world are index funds and dividend-paying stocks. So an even better thing,…
Recession Worries? Heres 1 of the Best Dividend Stocks for Turbulent Times
J.P. Morgan stated last month that it believes there is a 60% chance of a recession in 2025 due to…
2 High-Yield Dividend Stocks to Buy in May and Hold Forever
When investing in dividend stocks, paying attention to the right things is essential. A high yield can be attractive, but…